-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Vera Therapeutics, Raises Price Target to $73

Benzinga·12/05/2025 17:11:19
语音播报
TD Cowen analyst Ritu Baral maintains Vera Therapeutics (NASDAQ:VERA) with a Buy and raises the price target from $60 to $73.